ArticleIn vivo (Athens, Greece)

Serum Albumin Affects the Time-to-treatment Failure of Alectinib: A Multicenter Retrospective Study.

Kengo Umehara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.